Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT02882321 · TERMINATED
Trial details
- NCT number
- NCT02882321
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-29
- Primary completion
- 2022-04-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.